2019 glomerulonephritis pipeline review, h2 - biogen inc, omeros corp, pfizer inc & visterra inc - researchandmarkets.com

Dublin--(business wire)--the "glomerulonephritis - pipeline review, h2 2019" drug pipelines has been added to researchandmarkets.com's offering. glomerulonephritis is also known as glomerular nephritis (gn) or glomerular disease. it is a disease of the kidney, characterized by inflammation of the glomeruli. causes of glomerulonephritis include streptococcal infection of the throat known as strep throat, immune diseases, such as lupus, type 1 diabetes and type 2 diabetes and viruses, such as hiv
OMER Ratings Summary
OMER Quant Ranking